FDA Inspection 1058813 — The American National Red Cross Diagnostic Manufacturing Division
The FDA completed an inspection of The American National Red Cross Diagnostic Manufacturing Division on April 27, 2018 in Gaithersburg, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 27, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Gaithersburg, MD (United States)